Karyopharm Therapeutics
KPTI
KPTI
60 hedge funds and large institutions have $311M invested in Karyopharm Therapeutics in 2014 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 18 increasing their positions, 24 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
+6
Holders Change %
+11.11%
% of All Funds
1.73%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
15
Increased
18
Reduced
24
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
Franklin Resources
San Mateo,
California
|
+$37.7M |
2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
+$9.6M |
3 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$5.56M |
4 |
BlackRock
New York
|
+$2.37M |
5 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$2.27M |
Top Sellers
1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$17.9M |
2 |
Wellington Management Group
Boston,
Massachusetts
|
-$3.78M |
3 |
TG
TCW Group
Los Angeles,
California
|
-$3.57M |
4 |
Morgan Stanley
New York
|
-$3.22M |
5 |
![]()
Alyeska Investment Group
Chicago,
Illinois
|
-$1.72M |